Ondansetron Tablet, Orally Disintegrating
Product Images NDC 68071-4834

2 FDA label images from Nucare Pharmaceuticals,inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 68071-4834). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 4834 1)

Pdp (68071 4834 1)
Packaging label for Ondansetron 4 mg orally disintegrating tablets by NuCare Pharmaceuticals, Inc. The label indicates a package of 10 tablets with prescription use only. It includes manufacturer details, NDC 68071-4834-1, and dosing warnings like keeping out of reach of children and storage at controlled temperature.*
FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical Structure (Ondansetronod Str)
Chemical structure of Ondansetron, a medication represented by a multi-ring structure including an indole and an imidazole moiety with a methyl group and ketone functional group, consistent with the active ingredient Ondansetron.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.